Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study
- PMID: 27434045
- PMCID: PMC4951144
- DOI: 10.1371/journal.pmed.1002094
Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study
Abstract
Background: Whether and how n-3 and n-6 polyunsaturated fatty acids (PUFAs) are related to type 2 diabetes (T2D) is debated. Objectively measured plasma PUFAs can help to clarify these associations.
Methods and findings: Plasma phospholipid PUFAs were measured by gas chromatography among 12,132 incident T2D cases and 15,919 subcohort participants in the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct study across eight European countries. Country-specific hazard ratios (HRs) were estimated using Prentice-weighted Cox regression and pooled by random-effects meta-analysis. We also systematically reviewed published prospective studies on circulating PUFAs and T2D risk and pooled the quantitative evidence for comparison with results from EPIC-InterAct. In EPIC-InterAct, among long-chain n-3 PUFAs, α-linolenic acid (ALA) was inversely associated with T2D (HR per standard deviation [SD] 0.93; 95% CI 0.88-0.98), but eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were not significantly associated. Among n-6 PUFAs, linoleic acid (LA) (0.80; 95% CI 0.77-0.83) and eicosadienoic acid (EDA) (0.89; 95% CI 0.85-0.94) were inversely related, and arachidonic acid (AA) was not significantly associated, while significant positive associations were observed with γ-linolenic acid (GLA), dihomo-GLA, docosatetraenoic acid (DTA), and docosapentaenoic acid (n6-DPA), with HRs between 1.13 to 1.46 per SD. These findings from EPIC-InterAct were broadly similar to comparative findings from summary estimates from up to nine studies including between 71 to 2,499 T2D cases. Limitations included potential residual confounding and the inability to distinguish between dietary and metabolic influences on plasma phospholipid PUFAs.
Conclusions: These large-scale findings suggest an important inverse association of circulating plant-origin n-3 PUFA (ALA) but no convincing association of marine-derived n3 PUFAs (EPA and DHA) with T2D. Moreover, they highlight that the most abundant n6-PUFA (LA) is inversely associated with T2D. The detection of associations with previously less well-investigated PUFAs points to the importance of considering individual fatty acids rather than focusing on fatty acid class.
Conflict of interest statement
PWF has received consulting honoraria from Ely Lily & Co and Sanofi Aventis. CL receives a stipend as a specialty consulting editor for
Figures



Similar articles
-
Plasma phospholipid n-3 and n-6 polyunsaturated fatty acids in relation to cardiometabolic markers and gestational diabetes: A longitudinal study within the prospective NICHD Fetal Growth Studies.PLoS Med. 2019 Sep 13;16(9):e1002910. doi: 10.1371/journal.pmed.1002910. eCollection 2019 Sep. PLoS Med. 2019. PMID: 31518348 Free PMC article.
-
Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the Multi-Ethnic Study of Atherosclerosis.J Am Heart Assoc. 2013 Dec 18;2(6):e000506. doi: 10.1161/JAHA.113.000506. J Am Heart Assoc. 2013. PMID: 24351702 Free PMC article.
-
Associations between omega-6 polyunsaturated fatty acids, hyperinsulinemia and incident diabetes by race/ethnicity: The Multi-Ethnic Study of Atherosclerosis.Clin Nutr. 2020 Oct;39(10):3031-3041. doi: 10.1016/j.clnu.2020.01.003. Epub 2020 Jan 22. Clin Nutr. 2020. PMID: 32008872 Free PMC article.
-
Association of circulating fatty acids with cardiovascular disease risk: analysis of individual-level data in three large prospective cohorts and updated meta-analysis.Eur J Prev Cardiol. 2025 Feb 18;32(3):233-246. doi: 10.1093/eurjpc/zwae315. Eur J Prev Cardiol. 2025. PMID: 39365172 Free PMC article.
-
Gestational diabetes mellitus decreased umbilical cord blood polyunsaturated fatty acids: a meta-analysis of observational studies.Prostaglandins Leukot Essent Fatty Acids. 2021 Aug;171:102318. doi: 10.1016/j.plefa.2021.102318. Epub 2021 Jul 2. Prostaglandins Leukot Essent Fatty Acids. 2021. PMID: 34246926 Review.
Cited by
-
Plasma Amino Acids in Early Pregnancy and Midpregnancy and Their Interplay With Phospholipid Fatty Acids in Association With the Risk of Gestational Diabetes Mellitus: Results From a Longitudinal Prospective Cohort.Diabetes Care. 2023 Apr 1;46(4):722-732. doi: 10.2337/dc22-1892. Diabetes Care. 2023. PMID: 36701229 Free PMC article.
-
Plant-derived polyunsaturated fatty acids and markers of glucose metabolism and insulin resistance: a meta-analysis of randomized controlled feeding trials.BMJ Open Diabetes Res Care. 2019 Feb 8;7(1):e000585. doi: 10.1136/bmjdrc-2018-000585. eCollection 2019. BMJ Open Diabetes Res Care. 2019. PMID: 30899527 Free PMC article. Review.
-
ω-6 Polyunsaturated Fatty Acids and Cardiometabolic Health: Current Evidence, Controversies, and Research Gaps.Adv Nutr. 2018 Nov 1;9(6):688-700. doi: 10.1093/advances/nmy038. Adv Nutr. 2018. PMID: 30184091 Free PMC article.
-
Linoleic acid and the regulation of glucose homeostasis: A review of the evidence.Prostaglandins Leukot Essent Fatty Acids. 2021 Dec;175:102366. doi: 10.1016/j.plefa.2021.102366. Epub 2021 Oct 29. Prostaglandins Leukot Essent Fatty Acids. 2021. PMID: 34763302 Free PMC article. Review.
-
Blood Fatty Acid Profiles: New Biomarkers for Cardiometabolic Disease Risk.Curr Atheroscler Rep. 2018 Mar 20;20(5):22. doi: 10.1007/s11883-018-0722-1. Curr Atheroscler Rep. 2018. PMID: 29556735 Review.
References
-
- Eyre H, Kahn R, Robertson RM, Clark NG, Doyle C, Hong Y, et al. (2004) Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Circulation 109: 3244–3255. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 16491/CRUK_/Cancer Research UK/United Kingdom
- MR/N003284/1/MRC_/Medical Research Council/United Kingdom
- G1000143/MRC_/Medical Research Council/United Kingdom
- MC_UU_12015/1/MRC_/Medical Research Council/United Kingdom
- G0401527/MRC_/Medical Research Council/United Kingdom
- MR/P011705/1/MRC_/Medical Research Council/United Kingdom
- MC_UU_12015/5/MRC_/Medical Research Council/United Kingdom
- G0800783/MRC_/Medical Research Council/United Kingdom
- MC_UP_A090_1006/MRC_/Medical Research Council/United Kingdom
- MC_PC_13030/MRC_/Medical Research Council/United Kingdom
- 001/WHO_/World Health Organization/International
- MR/P01836X/1/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials